NATO Defense Spending Surge and US Troop Deployment to Poland Signal Shift in European Security London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance UK Exports to US Plunge 25 Following Trump Tariff Announcement Fraudsters Forged Paperwork Too Modern Foils Fake Statue Scheme at Sothebys Billionaire Philippe Laffont Rotates from Cloud Giants to AI Chip Infrastructure Nvidias Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Retreat OXM Q1 2026 Earnings Major EPS Miss but Stock Surges 8 TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment NVCR Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment ABNB Q1 2026 Earnings EPS Falls Short as Stock Dips Modestly PermaFix Environmental Services PESI Q1 2026 Earnings Significant EPS Miss Amid No Reported Revenue Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status Satellogic Warrants SATLW Plunge 11 Key Support Levels in Focus Spectral AI Inc MDAI Edges Higher Nearing Key Resistance as Momentum Shifts Adobe Inc ADBE Edges Higher Amid Consolidation Holds Above Key Support Smurfit WestRock SW Holds Steady Near MidRange as Investors Eye Resistance Levels Linkhome Holdings Inc LHAI Holds Steady at 090 as Key Levels Define Trading Range USA Rare Earth Surges 13 Amid USChina Trade Deal Uncertainty VUZI Q1 2026 Earnings EPS Beat and Narrowed Loss Boost Investor Sentiment NexPoint Residential Trust NXRT Slides Slightly While Holding Above Key Support Levels Coty Q1 2026 Earnings A Narrow EPS Miss Amid Lingering Challenges Instil Bio Q1 2026 Earnings EPS Miss as DevelopmentStage Company Reports No Revenue Stock Edges Up SSC Technologies SSNC Q1 2026 Earnings EPS Slightly Beats Estimates Despite Modest Stock Decline QURE Q1 2026 Earnings Narrower Loss Than Expected but Stock Declines on Lack of Revenue OCSL Q1 2026 Earnings EPS Beats Estimates Stock Gains Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline YELP Q1 2026 Earnings EPS Beat by 117 Amid Modest Stock Uptick